Recombinant human antibody to Env. PGDM1405, is not broadly neutralizing (22%) but potent (median IC50 = 0.006 µg/ml) when tested against a 77-virus cross-clade panel.
Figure 1 Despite differences in neutralization, somatic variants bind to the same region on Env.
The somatic variants PGDM1400–1407 all bind to the BG505 SOSIP.664-AviB construct by ELISA.
Sok, D., van Gils, M. J., Pauthner, M., Julien, J. P., Saye-Francisco, K. L., Hsueh, J., ... & Hua, Y. (2014). Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex. Proceedings of the National Academy of Sciences, 111(49), 17624-17629.
Figure 2 Somatic variants bind to cell-surface BG505 Env despite not neutralizing the BG505 pseudovirus.
Somatic variants were tested for binding to BG505 Env expressed on the surface of 293T cells. Antibody PGT151, which binds specifically to cleaved Env, and antibody b6, which binds to uncleaved Env, were included for comparison.
Figure 3 Binding of mAbs to BG505 SOSIP.664-aviB by Octet.
Antibodies PGT145, PGDM1400, PGDM1401, PGDM1403, PGDM1405, and PGDM1407 were analyzed for binding to BG505 SOSIP.664-AviB by Octet.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-057 | Recombinant Anti-HIV-1 env VHH Single Domain Antibody | ELISA, IHC, FC, FuncS | Llama VHH |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-137 | Human Anti-HIV-1 Env Recombinant Antibody (clone PGT124) | WB, Neut, FuncS | Human IgG |
PABL-141 | Human Anti-HIV-1 Env Recombinant Antibody (clone 35O22) | WB, ELISA, Neut, FuncS | Human IgG |
PABL-143 | Human Anti-HIV-1 Env Recombinant Antibody (clone 9H+3L) | WB, ELISA, IF, FuncS | Human IgG |
PABL-144 | Human Anti-HIV-1 Env Recombinant Antibody (clone C11) | WB, ELISA, FuncS | Human IgG |
PABL-145 | Human Anti-HIV-1 Env Recombinant Antibody (PABL-145) | ELISA, Neut, FuncS | Human IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-379 | Human Anti-HIV-1 Env Recombinant Antibody (clone VRC0); scFv Fragment | Neut, FuncS | Human scFv |
PSBL-381 | Human Anti-HIV-1 Env Recombinant Antibody (clone VRC07); scFv Fragment | WB, ELISA, FuncS | Human scFv |
PSBC-420 | Human Anti-HIV-1 Env Recombinant Antibody (clone CAP228-3D); scFv Fragment | Neut | Human scFv |
PABJ-0039-S(P) | Human Anti-HIV-1 Env Recombinant Antibody (clone 1-55); scFv Fragment | ELISA, Neut | Human scFv |
PABJ-0053-S(P) | Human Anti-HIV-1 Env Recombinant Antibody (clone 1-18); scFv Fragment | ELISA, Neut | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-2742CQ-F(E) | Human Anti-HIV-1 Env Recombinant Antibody (clone 10.9D); Fab Fragment | ELISA | Human Fab |
MRO-2743CQ-F(E) | Human Anti-HIV-1 Env Recombinant Antibody (clone 6.1C); Fab Fragment | ELISA | Human Fab |
MRO-2744CQ-F(E) | Human Anti-HIV-1 Env Recombinant Antibody (clone 8.9D); Fab Fragment | ELISA | Human Fab |
MRO-2745CQ-F(E) | Human Anti-HIV-1 Env Recombinant Antibody (clone 12A16); Fab Fragment | Neut | Human Fab |
MRO-2746CQ-F(E) | Human Anti-HIV-1 Env Recombinant Antibody (clone 12A20); Fab Fragment | Neut | Human Fab |
There are currently no Customer reviews or questions for MRO-2785CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.